Status | Study |
Recruiting |
Study Name: Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) Condition: Leptomeningeal Metastasis Date: 2014-02-21 |
Terminated |
Study Name: Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System Condition: Leukemia Lymphoid Malignancies Metastatic Malignant Neopla Date: 2012-05-08 Interventions: Drug: Intrathecal Rituximab Phase I: Starting dose Rituxim |
Withdrawn |
Study Name: Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal Disease Condition: Leptomeningeal Metastases Date: 2011-09-19 Interventions: Other: pharmacological study C |
Terminated |
Study Name: Depocyt® With Sorafenib in Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-08-24 Interventions: Drug: DepoCyt Patients were to |
Completed |
Study Name: A Pilot Study of Bevacizumab for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2009-06-18 Interventions: Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks. |
Completed |
Study Name: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-12-21 Interventions: Drug: Topotecan |
Terminated |
Study Name: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis Condition: Neoplastic Meningitis Date: 2007-08-13 Interventions: Drug: DepoCyt Starting dose of |
Completed |
Study Name: Phase I Study of Intrathecal Mafosfamide Condition: Leukemia Lymphoma Meningeal Neoplasm Date: 2006-07-07 Interventions: Drug: Mafosfamide |
Terminated |
Study Name: Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine Condition: Meningitis Neoplasms Date: 2003-12-16 Interventions: Drug: Gemcitabine Schedule |
Completed |
Study Name: Intrathecal Mafosfamide Condition: Malignant Meningeal Neoplasms Date: 2003-06-17 Interventions: Drug: Intrathecal Mafosfamide |